South Asian (SA) patients are known to have an increased incidence of acute cardiovascular events compared with Caucasians. The aim of this observational study was to compare the prevalence of coronary stenoses, the amount and composition of coronary atherosclerosis in a cohort of Caucasian and SA patients with stable chest pain, in non-acute settings.
Introduction
People of South Asian (SA) ethnicity constitute a quarter of the world's population and face an increased risk of premature coronary artery disease (CAD), a pattern recorded among Indians in urban India and among SA migrants in other countries. 1 -4 In SA people, there is greater incidence of early myocardial infarction, cardiovascular mortality, and a higher number of traditional cardiovascular risk factors compared with other ethnicities. 5, 6 Whether cardiovascular risk factors can adequately explain this high number of events is controversial. 7, 8 Evidence that plaque characteristics such as total plaque burden and composition as well as coronary stenosis may yield independent incremental prognostic value in both symptomatic and asymptomatic subjects is becoming increasingly available. 9 -12 Ethnic differences in the prevalence of coronary stenoses, atherosclerotic plaque burden, and composition could have implications for understanding the mechanism behind the increased risk of developing acute events in SA people, which may not be fully explained by differences in classical cardiovascular risk factors. Data in the SA ethnicity are lacking. 10 Coronary computed tomography angiography (CTA) has emerged as a non-invasive technique for the detection of CAD. The feasibility of CTA as a method to detect early coronary atherosclerosis and assess plaque composition in stable and unstable patients has been previously reported. 13, 14 Available semi-automated software tools to quantitatively measure coronary plaques have shown good accuracy and reproducibility. 15 -19 The purpose of this observational study was to determine whether the prevalence of coronary stenoses, the burden, and composition of coronary atherosclerotic plaque were associated with SA ethnicity and if any difference persisted after adjustment for cardiovascular risk factors in a cohort of patients with stable, non-acute chest pain.
Methods

Study population
All patients underwent physician-referred coronary CTA and gave written informed consent to the use of the data for research purposes. 20 The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and received approval by the local Research Ethics Committee.
We screened 2635 consecutive patients who had coronary CTA between 2010 and 2012 in a tertiary hospital in the borough of Tower Hamlets, East London, UK. Inclusion criteria were stable chest pain due to suspected CAD and Caucasian or SA ethnicity (first-generation migrants). Exclusion criteria were contraindications to coronary CTA such as impaired kidney function (eGFR ,30 mL/min), suspected or known allergy to iodinated contrast and inability to lay flat. Pregnant women were also excluded. Also not included were patients with known CAD, previous acute myocardial infarction (AMI), previous percutaneous coronary angioplasty (PCI), or coronary artery bypass graft (CABG) surgery, patients being evaluated prior to valve replacement procedures and with cardiomyopathies (Appendix I; Figure 1 ). Both ethnic groups lived in the same borough in East London, and patients were evaluated at a single, public National Health Service (NHS) tertiary hospital with standardized care protocols and pathways.
Cardiovascular risk factors and type of chest pain
Data on cardiovascular risk factors were obtained through standardized patient questionnaires administered prior to the scans and were checked with information held in the hospital's electronic medical records. The type of chest pain was classified as typical, atypical, or nonanginal 21 (definitions given in the Appendix I). Data fields that could not be observed or obtained from the medical records were coded as missing.
Coronary CTA acquisition and analysis
A second-generation, dual-source CT scanner (Somatom Definition Flash, Siemens, Forchheim, Germany) was used. First, the Agatston calcium score was measured on a commercially available workstation (Syngo MultiModality Workplace VE25A, Siemens, Forchheim, Germany) by a single experienced observer using dedicated software (Syngo Calcium Score). No patients were excluded from the study due to a high calcium score. Then, the image quality of coronary CTA was graded as good, adequate, or poor (details in Appendix I). Datasets with good or adequate image quality were included for plaque quantification using a validated semi-automated software tool (Autoplaq, version 8.9, Cedars-Sinai Medical Centre, Los Angeles, CA, USA). 16 A single independent, blinded observer inspected all coronary segments with a diameter above 1.5 mm according to a modified 18-segment anatomical model. 22 Segments with visually detectable coronary plaque were further analysed with semi-automated software ( Figure 2 ). Atherosclerotic plaque was Figure 1 Inclusion procedure.
defined as any clearly discernible structure .1 mm 2 in diameter that could be assigned to the coronary wall on at least two consecutive sections. 23 The segment involvement score (SIS) was defined as the number of coronary segments containing any plaque. The per cent area stenosis and diameter stenosis in each coronary segment were calculated using a simplified method 24 (Appendix I). Coronary artery diameter stenosis was reported using a 5-grade ordinal scale; 0, no stenosis; 1, 1 -24% stenosis; 2, 25 -49% stenosis; 3, 50 -69% stenosis; 4, 70 -89% stenosis; 5, ≥90% stenosis. 25 The severity of disease on a patient level was reported as the maximum stenosis per patient and the number of vessels with at least one ≥50% diameter stenosis (one-, two-, three-vessel disease, left main (LM) disease). The remodelling index (RI) was calculated as the ratio between the total cross-sectional vessel area (including both plaque and vessel lumen) at the site of worst per cent area stenosis and the mean crosssectional vessel area between the proximal and distal reference sites. 26 Non-calcified plaque and calcified plaque were distinguished based on a scan-specific threshold level-based algorithm. The procedure of semi-automatic plaque measurement is further described in the Appendix I and detailed in a previous publication. 16 Low-density, non-calcified plaque (a sub-type of non-calcified plaque with particularly low attenuation) was defined as non-calcified plaque with attenuation values lower than 30 Hounsfield Units, in keeping with previously published data. 27 To measure the atherosclerotic plaque burden, first the segmental noncalcified, calcified, and total plaque volumes were measured within the same patient and were summed to derive per-patient non-calcified, calcified, and total plaque volumes. Non-calcified plaque burden, calcified plaque burden, and total plaque burden were calculated as 100 × (plaque volume/vessel volume). The vessel volume in the denominator included both the vessel wall (including any plaque in it) and lumen. The plaque volume is a measured plaque parameter, where the plaque burden is normalized to the patient's individual coronary vessel volume, and was used in the analyses. Per cent non-calcified plaque composition was derived as 100 × (non-calcified plaque volume/total plaque volume).
Statistical methods
Categorical data were summarized as frequencies and percentages, and compared using x 2 test or Fisher's exact test when x 2 approximation could be incorrect. Continuous variables were presented by both mean with standard deviation (SD) and median with inter-quartile range (IQR). Variables were compared using Mann-Whitney U test without assuming the normal distribution. To confirm the suitability of nonparametric testing, Shapiro -Wilk test was used to test for normality of continuous variables. Most of the continuous variables were not normally distributed by Shapiro -Wilk test, including per cent coronary diameter stenosis, no. of vessels with ≥50% diameter stenosis, minimal luminal diameter and area, per cent area stenosis, RI, SIS, Agatston calcium score, and plaque burden. All P-values were ,0.001.
To assess the effect of the exposure variable ethnicity on continuous outcome variables of plaque characteristics, we applied propensity score (PS) matching and weighting to adjust for potential confounders available in our retrospective database. 28 Potential confounders included in the model were age, gender, hypertension, hyperlipidaemia/ cholesterol-lowering medication, diabetes, smoking status, type of chest pain, and family history. The propensity score was produced using logistic regression, and then propensity score weighting was applied to Mann-Whitney regression without assuming the normality of residual distribution. 29 For comparison, we also applied general multivariate linear regression (MLR) adjusting for the same baseline confounders used to produce propensity scores. The drawback here is that the normality assumption on the residuals may not be met. 
Results
The inclusion procedure is shown in Figure 1 . Of 1067 patients (464 Caucasians and 603 SA), good or adequate image quality on coronary CTA was found in 963/1067 (90.25%) patients. Patients with poor image quality (104/1067; 9.75%) were excluded from further analysis.
Baseline characteristics
The study population consisted of 963 patients of whom 420 were Caucasian and 543 were SA. Between Caucasians and SA, there were no significant differences in gender distribution (P-value ¼ 0.586), prevalence of hypertension (P-value ¼ 0.562), and the type of chest pain (P-value ¼ 0.630). On average, Caucasians were older than SA (54.39 + 11.65 vs. 49.83 + 11.03 years; P-value ,0.001), with a lower prevalence of diabetes (13.13 vs. 32.41%; P-value ,0.001) and hyperlipidaemia (56.90 vs. 68.51%; P-value ¼ 0.001). Caucasians had a higher prevalence of smoking than SA (50.24 vs. 30.94%; P-value ,0.001) ( Table 1) .
Coronary CTA
Between Caucasians and SA, we observed no difference in the SIS (P-value ¼ 0.208) and in the number of vessels with ≥50% diameter stenosis, i.e. one-, two-, three-vessel disease, and/or LM disease (P-value ¼ 0.559). Similarly, there was no significant difference in coronary minimal luminal diameter (P-value ¼ 0.216), minimal luminal area (P-value ¼ 0.290), and per cent area stenosis (P-value ¼ 0.342) ( Table 2) .
Caucasians had slightly higher Agatston score than SA (121.80 vs. 56.65; P-value ¼ 0.002), higher calcified plaque burden (2.89 vs. 1.40%; P-value , 0.001), and lower non-calcified plaque burden (13.43 vs. 14.69%; P-value ¼ 0.002). Despite these differences, there was no significant difference in total plaque burden (P-value ¼ 0.889) and RI (P-value ¼ 0.792). In patients with atherosclerotic plaque, the per cent non-calcified plaque composition was lower in Caucasians compared with SA (80.95 vs. 90.42%; P-value ,0.001) ( Table 2 ).
In the sub-analysis by diabetes (Table 3) , non-calcified and calcified plaque burden, as well as non-calcified plaque composition remained different between Caucasian and SA patients, regardless of whether or not the patients had diabetes. In this sub-analysis, not adjusted by age nor by the other cardiovascular risk factors, differences between ethnic groups in per cent coronary diameter stenosis (P ¼ 0.033), per cent area stenosis (P ¼ 0.006), RI (P ¼ 0.017), SIS (P ¼ 0.001), and Agatston calcium score (P , 0.001) were seen in the non-diabetic group, but not in the diabetic group.
After propensity score matching, there were no significant differences in covariates between ethnic groups ( Table 4) . A significant association between Caucasian ethnicity and Agatston calcium score, calcified plaque burden, as well as calcified plaque composition remained, as shown by propensity score matching, propensity score weighting, and MLR (Table 5, Figure 3) .
The association between SA ethnicity and non-calcified plaque burden remained by propensity score weighting, but not by the other two approaches. Both of these variables were not normally distributed according to Shapiro -Wilk test, thus using MLR may have caused bias. Propensity score exact matching, on the other hand, despite a more rigorous adjustment for confounders, reduced the power of testing using a much smaller sample size. SA ethnicity, however, remained associated with non-calcified plaque composition by all three approaches.
Discussion
In a cohort of consecutive symptomatic patients with stable chest pain undergoing coronary CTA, we observed ethnic differences between Caucasians and SA in the composition of atherosclerotic plaque that were not fully explained by available, classical cardiovascular risk factors. SA patients presented with chest pain at a younger age and had higher rate of diabetes, which was roughly 2.5 times the rate in Caucasians. A similar difference in age and prevalence of diabetes was found previously between SA and Caucasian patients receiving percutaneous revascularization in the setting of an acute coronary syndrome. 30 We found no difference in the severity of coronary atherosclerosis expressed as either the per cent area stenosis or the number of vessels with at least one ≥50% diameter stenosis (one-, two-, three-vessel disease, and LM disease). However, the per cent non-calcified plaque composition was lower in Caucasians compared with SA. Caucasians had slightly higher calcified plaque burden than SA, although this difference was small. Our study has two important features. First, we included a large group of SA subjects lacking in many of the previous studies. Secondly, the majority of previous studies evaluated coronary calcification on non-contrast electron-beam computed tomography (EBCT). We used coronary CTA to evaluate quantitatively calcified as well as non-calcified plaque burden together with coronary artery stenosis. We report on coronary plaque phenotype (quantity of plaque, composition, stenosis) in Caucasians and SA cohorts with stable chest pain but overall with a low prevalence of obstructive CAD, reflecting relatively early atherosclerotic stages. Evidence that plaque characteristics such as plaque burden and composition as well as coronary stenosis may yield incremental prognostic value both in symptomatic and in asymptomatic subjects is becoming increasingly available and may gain increasing importance for patient management, especially in populations at higher risk. 9 -12 In the population-based Multi-Ethnic Study of Atherosclerosis (MESA), 31 the amount of coronary calcifications measured with non-contrast EBCT was higher in Caucasian subjects compared with other ethnicities such as Chinese, Hispanic, and African American subjects. Similarly, in another non-contrast EBCT study of asymptomatic individuals referred by their physician for cardiovascular risk assessment, Caucasians had a higher relative risk of having coronary calcification compared with Hispanic and African American subjects.
32
A study by Kanaya et al. 33 (MASALA study) looked at a prospective community-based cohort of asymptomatic SA individuals in the USA and compared the coronary artery calcium score with that of the other ethnic groups included in the MESA study. In this study, the SA group was younger and had higher prevalence of diabetes, hyperlipidaemia, and lower prevalence of cigarette smoking compared with Caucasian, in exact agreement with our findings. The crude prevalence of coronary calcification (any detectable calcium score vs. zero calcium score) was higher in Caucasians compared with SA. After adjusting for age and covariates, Caucasian and SA subjects had similar calcium scores. This is not in contrast with our study where the difference in calcified plaque burden between Caucasian and SA patients was statistically significant but small. However, not all coronary plaques are calcified, and calcification may lead to underestimation of the total amount of coronary atheroma. 23 In our study, coronary CTA allowed the assessment of noncalcified and calcified components as well as total atherosclerotic plaque. We found a 10% higher non-calcified plaque composition in SA compared with Caucasians. However, we also observed a younger age and a higher rate of diabetes in SA. The amount of coronary calcification is known to increase with age. 34 This baseline difference was also observed in SA and Caucasian patients receiving revascularization in the context of acute coronary syndromes. 30 The same pattern was also observed in the study by Kanaya et al. 33 looking at a prospective, community-based cohort of asymptomatic subjects without known CAD. A higher proportion of non-calcified plaque in diabetic patients compared with non-diabetics was reported using invasive 35 The limitation of multivariate linear regression is that the assumption of normality of response variable may not be met.
a Multivariate linear regression includes independent variables: Caucasian and all the variables (see Table 4 ) involved in propensity score calculation.
A study by Roos et al. 38 using coronary CTA included 240 Caucasian and SA asymptomatic patients all with diabetes. In this study, where all patients were diabetic and were matched by age, gender, and duration of diabetes, the authors found that SA had more advanced atherosclerosis with a higher number of vessels with ≥50% diameter stenosis compared with Caucasians. Although noncalcified plaque was not evaluated in this study, findings suggested that ethnicity and not only differences in risk factors might have an effect on the atherosclerotic process, in keeping with our findings. Another study by Koulaouzidis et al. 39 looked at 101 Caucasian and SA symptomatic patients matched for age, gender, and the presence of diabetes. In this cohort, coronary atherosclerosis was much more advanced than in our study and this was particularly in SA compared with Caucasians: 26% of SA and 6% of Caucasian patients had three-vessel disease, 14% of SA and 28% of Caucasians had one-vessel disease. SA patients had more calcified as well as non-calcified plaques (visually assessed) compared with Caucasians. Since patients were matched for age, gender, and the presence of diabetes, the authors excluded conventional risk factors as an explanation for these differences, again suggesting a role for ethnicity. Due to inherent limitations in spatial resolution, the analysis of plaque characteristics by coronary CTA is rather crude. First, the visual impression of coronary calcifications on CTA images is affected by the 'blooming effect' that exaggerates the size of calcifications. Because this is a known challenge, in this study we used a scan-specific, threshold level-based software tool to quantify and classify coronary plaques as calcified or non-calcified. Secondly, the fibrous tissue component and lipid-rich (or necrotic) core of a coronary plaque cannot always be distinguished hence both will contribute to the non-calcified plaque volume detected on coronary CTA. The per cent non-calcified plaque composition found in our study likely reflects the sum of a larger fibrous tissue component and a smaller lipid-rich component, in keeping with histology data. 40 The ability to identify selectively and accurately low-density, non-calcified plaques associated with a thin fibrous cap (a histopathological entity called thin-cap fibroatheroma) could provide a more sophisticated parameter to identify patients at higher risk of acute coronary events. However, this task appears rather unrealistic with current non-invasive imaging technology. Despite these limitations, the clinical value of straightforward plaque characteristics such as estimated quantity of plaque (plaque burden) and composition, as well as coronary stenoses, has been previously shown for evaluating plaque progression/regression and refining prognostication. 9, 12 The magnitude of the plaque burden expressed as the number of plaques or the number of diseased segments (SIS) in combination with stenosis severity scores was also reported as directly associated with worse prognosis in both nondiabetic and diabetic patients.
11,41
We acknowledge a few study limitations. First, this is a crosssectional study. Clinical outcome data were not available. Given that a small proportion of these stable patients had ≥50% coronary stenosis, long follow-up times will be necessary to collect meaningful numbers of hard events (death, myocardial infarction). The observational data included in this study however offer an insight into earlier, non-acute stages of coronary atherosclerosis. Secondly, there may be residual confounding factors such as incomplete adjustment for physical activity levels, inflammatory biomarkers, vitamin D levels, cultural factors (consumption of high salt and high glycaemic index foods), and socioeconomic status (income and education). After propensity score exact matching, the power of testing was reduced using a much smaller sample size. Thirdly, the physician's knowledge of SA patients being at higher risk for acute coronary events at younger ages might as well induce an earlier referral to diagnostic testing compared with Caucasians, leading to selection bias. However, both ethnic groups lived in a single borough in East London and were evaluated at a single, public NHS tertiary hospital with standardized care protocols and pathways. Nevertheless, we acknowledge that generalizability of our results may be limited given that we used data from a single tertiary centre in the UK.
In conclusion, this observational study carried out in non-acute settings showed a difference in composition of coronary atherosclerotic plaque between Caucasian and SA patients not entirely explained by cardiovascular risk factors. SA patients had higher per cent non-calcified plaque composition compared with Caucasians. Further longitudinal research is warranted to evaluate the mechanistic and clinical significance of this difference in phenotype, which may be related to ethnicity or to more complex interactions between ethnicity and risk factors.
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Appendix 1 Study population
The ethnicity recorded was that declared by the patient. SA ethnicity describes patients of Indian, Pakistani, Bangladeshi, Sri Lankan, or Nepalese origin, as previously described. 42 The SA people included in this study were first-generation migrants living in the borough of Tower Hamlets (London, UK). 43 This study did not aim to perform comparison among first-, second-, and thirdgeneration migrants, because a balanced mix is not observed in our practice.
Cardiovascular risk factors and type of chest pain
Diabetes was defined as a fasting blood glucose level above 126 mg/dL (7 mmol/L) or requirement for insulin or oral hypoglycaemic drugs. Hyperlipidaemia was defined as a total cholesterol level above 200 mg/dL (5.18 mmol/L). Use of cholesterol-lowering medication was dichotomized into on treatment and not on treatment. Hypertension was defined as blood pressure above 140/90 mmHg or use of anti-hypertensive medication. Smoking was dichotomized into never smokers and smokers (current and former). Family history of coronary heart disease was defined as having first-or seconddegree relatives with premature CAD (age ,50 years for men, ,55 years for women). Typical chest pain was defined as having (i) substernal chest pain or discomfort, that is (ii) provoked by exertion or emotional stress and (iii) relieved by rest and/or nitroglycerine. 21 Atypical chest pain was defined as having two of the before-mentioned criteria. When one or none of the criteria was present, the patient was classified as having non-anginal chest pain.
Coronary CTA acquisition
Patients with resting heart rates .65 bpm and no contraindications were given 5 -35 mg i.v. metoprolol until a desired heart rate of ≤65 bpm was reached. All patients underwent a non-enhanced calcium scoring scan using a prospectively ECG-triggered high pitch spiral technique with the following parameters: 2 × 64 × 0.6 mm collimation, 280 ms gantry rotation time, a pitch of 3.4, 120 kV tube voltage, and 150 mA tube current. Images were reconstructed with a 3 mm slice thickness and an increment of 1.5 mm. Coronary CTA was performed with a sequential, prospectively ECG-triggered (step-and-shoot) protocol with the following parameters: 2 × 64 × 0.6 mm collimation with z-flying focal spot for both detectors, 280 ms gantry rotation time, tube voltage of 100/120 kV (,90 kg/≥90 kg), and a maximum tube current of 370 mAs. The imaging window was set at 70% of the R -R interval for heart rates ,70 bpm and was prolonged to include 40 -70% of the R -R interval for heart rates ≥70 bpm. The optimal scan delay was determined by injection of 15 mL of iodinated contrast (300 mgI/mL, Omnipaque, GE Healthcare, UK) with an injection rate of 7.0 mL/s. Scan time was 6-8 s with this protocol. A volume of 60 mL of contrast was injected followed by 40 mL saline chaser with the same injection rate to ensure consistent intracoronary attenuation across the scan range. Coronary CTA images were reconstructed at the best mid-to-end diastolic phase (and systolic phase when available) with a 0.75 mm slice thickness and a 0.4 mm increment using a dedicated (B26f) convolution filter. The median (IQR) dose length product (DLP) associated with the protocol was 202 (115-402) mGy cm.
Coronary CTA analysis
Image quality of coronary CTA datasets was graded as good, adequate, or poor. Good image quality was defined as a clear delineation of the coronary arteries without motion artifacts. Adequate image quality was defined as mild motion artifacts and blurring of the vessel wall. Poor image quality was defined as severe motions artifacts, severely blurred vessels, and/or poor signal-to-noise-ratio. Datasets with good or adequate image quality were analysed using a validated semi-automated software tool (Autoplaq, version 8.9, Cedars-Sinai Medical Centre, Los Angeles, CA, USA) 16 that applies a scan-specific threshold level-based quantification method. A single independent, blinded observer inspected all coronary segments with a diameter above 1.5 mm according to an 18-segment anatomical model. 22 Segments with visually detectable coronary plaque were further analysed with semi-automated software ( Figure 2) . Atherosclerotic plaque was defined as any clearly discernible structure .1 mm 2 in diameter that could be assigned to the coronary wall on at least two consecutive sections. 23 First a 1-cm 2 region of interest was placed in the aorta to define blood pool attenuation. Using the most representative longitudinal image of the coronary vessel of interest, two points were placed in the vessel marking the proximal and distal vessel reference points. Then the vessel centerline was manually drawn between these points, and the plaque characteristics were quantified as described below with the vessel wall edited if necessary. Because the intra-arterial injection of iodinated contrast results in enhancement of the arterial lumen as well as significant enhancement of the vessel wall and atherosclerotic plaque, 44, 45 plaque attenuation may vary with intracoronary attenuation. Cademartiri et al. 46 demonstrated that plaque attenuation varied significantly also with the reconstruction kernel. The approach used here used scan-specific attenuation thresholds for non-calcified plaque and calcified plaque components, which were automatically determined from luminal attenuation. In addition to the CTA data, the algorithm required as input a region of interest in the aorta defining the normal blood pool, five to seven control points in the arterial lumen along the plaque, from which luminal centrelines were derived, and two points marking the start and the end of the artery to be analysed. To calculate scan-specific thresholds for non-calcified and calcified plaque, previously published algorithms 47 for non-contrast cardiac CT were implemented, adding specific consideration to the scanspecific variation in contrast distribution through the coronary arteries. Non-calcified and calcified plaque components were automatically classified within the arterial wall by an iterative, recursive 3D region-growing algorithm, which expanded from a starting seed voxel similar to an expanding 3D balloon. The seed voxel was first localized from the cross-sectional plane with the greatest luminal stenosis. The classified voxels were displayed with colour-coded overlay and volumetric readings provided in the analysis output. The analysis procedure and mathematical algorithm were previously described in detail. 16 This algorithm was previously validated showing robust inter-observer agreement, expressed by r ¼ 0.83 for total plaque, r ¼ 0.90 for calcified plaque, 0.93 for non-calcified plaque, and 0.96 for non-calcified plaque composition. 15 Inter-observer mean per cent differences were 0.3% for calcified plaque and 0.1% for non-calcified plaque. 18 Intra-observer agreement was also proven robust with r ¼ 0.97 for both total plaque and calcified plaque, and r ¼ 0.96 for both non-calcified plaque and non-calcified plaque composition. 15 Intra-observer mean per cent differences were 0.4%
for calcified plaque and 0.3% for non-calcified plaque. 18 Variability in estimating plaque burden, however, would have equally impacted on both ethnicities, without impairing the between-cohorts comparison reported in this study. The per cent area stenosis and diameter stenosis in each coronary segment were calculated using a simplified method that estimates the normal tapering of the coronary artery. 24 This method requires measurement of the following: reference luminal area proximal to stenosis (Aprox), reference luminal area distal to stenosis (Adis), minimal luminal area at the site of stenosis (Asten), distance between proximal reference site and distal reference site (X1), and distance between proximal reference site and minimal luminal diameter (X2). The per cent area stenosis was derived as
